Amount of donor allowance and criteria for special care allowance to change in January
17.12.2025 12:50:14 EET | Kela/FPA | Press release
Parliament has approved amendments to the Health Insurance Act that introduce changes to the amount of sickness allowance paid on account of human cell, tissue or organ donation (donor allowance) and the criteria for granting special care allowance.
After the amendments enter into force, donor allowance (luovutuspäiväraha) will compensate the donor for their actual loss of income due to cell, tissue or organ donation and any necessary associated tests or examinations. Under the current rules, donor allowance is calculated on the basis of annual income in the same way as sickness allowance. In 2024, Kela paid donor allowance to 41 recipients.
Specifications made to the criteria for granting special care allowance
As of 1 January 2026, the criteria for granting special care allowance (erityishoitoraha) will be specified so that, going forward, the most crucial criterion is the level of care instead of the place of care. Kela can pay special care allowance to parents who participate in specialist-level treatment or rehabilitation that is given to their child due to the child’s illness, medical condition or disability. Specialist-level treatment can also be provided outside hospitals or hospital outpatient clinics. In 2024, Kela paid special care allowance to 4,840 recipients.
The amendments will enter into force on 1 January 2026. They will not apply to donor allowance or special care allowance that was granted before 1 January 2026.
Read more
Sickness allowance on account of human cell, tissue or organ donation (kela.fi)
Special care allowance (kela.fi)
Keywords
Contacts
Milla Kaitolabenefits managerKela
Tel:0505517938milla.kaitola@kela.fiKela's Communications UnitFor media enquiries, please contact us between 9:00 and 16:00, Monday to Friday. This number can be used for interview requests, which we will be happy to forward to an appropriate source at Kela. You can also submit interview requests by email.
Tel:+358 20 634 7745viestinta@kela.fiKela has a responsibility to provide basic support in life’s ups and downs to everyone covered by the Finnish social security system.

Alternative languages
Subscribe to releases from Kela/FPA
Subscribe to all the latest releases from Kela/FPA by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Kela/FPA
Ersättningarna för privatläkararvoden ökade år 2025 med 20 procent jämfört med året innan21.9.2026 11:04:22 EEST | Pressmeddelande
År 2025 betalade FPA 107 miljoner euro i ersättningar för privatläkararvoden. Över 1,5 miljoner personer fick ersättning. De här uppgifterna framgår av FPA:s sjukförsäkringsstatistik 2025.
Yksityislääkärin palkkiosta maksetut korvaukset kasvoivat vuonna 2025 edellisvuodesta 20 prosenttia21.9.2026 11:04:22 EEST | Tiedote
Kela maksoi vuonna 2025 yksityislääkärin palkkioista korvauksia 107 miljoonaa euroa ja korvausta sai yli 1,5 miljoonaa henkilöä. Luvut selviävät Kelan sairausvakuutustilastosta 2025.
Var nionde person som fyllt 65 år utnyttjade valfrihetsförsöket under det första året16.9.2026 06:00:00 EEST | Pressmeddelande
Valfrihetsförsöket har utnyttjats mest i Mellersta Nylands välfärdsområde. Den vanligaste orsaken till läkarbesöken är sjukdomar i rörelseorganen.
Joka yhdeksäs 65 vuotta täyttänyt hyödynsi valinnanvapauskokeilua sen ensimmäisen vuoden aikana16.9.2026 06:00:00 EEST | Tiedote
Valinnanvapauskokeilua on hyödynnetty eniten Keski-Uudenmaan hyvinvointialueella. Yleisin syy hakeutua vastaanotolle ovat tuki- ja liikuntaelinten sairaudet.
Den långvariga nedgången i födelsetalen verkar nå en vändpunkt i år, visar FPA:s statistik över moderskapsunderstöd15.9.2026 06:00:00 EEST | Pressmeddelande
Under januari–juni 2026 ökade antalet ansökningar om moderskapsunderstöd från FPA med cirka 11 procent jämfört med motsvarande period i fjol.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom